Varying Coefficient Landmark Models for Predicting Long-Term Survival Using Longitudinal Predictors

来源 :泛华统计学会(icsa)2015年学术会议 | 被引量 : 0次 | 上传用户:hhugjl012800
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
For most oncology studies,the long-term survival outcome is a typical endpoint for large-scaled confirmatory(phase Ⅲ) studies,while some short-term outcome(e.g.remission rate) that is measured or computed as a specific given time point is generally used as a primary endpoint during the earlier phases(phase Ⅰ or Ⅱ) of the study.
其他文献
Model selection methods are proposed for different models.Some are restricted to specific models and others require strict conditions which are probably hard to
会议
Markov chain Monte Carlo(MCMC) methods have proven to be a very powerful tool for analyzing data of complex structures.However,their computer-intensive nature,w
会议
The Cancer Genomes Atlas(TCGA) data are unique in that multimodal measurements across genomics features,such as copy number,DNA methylation,and gene expression,
会议
会议
This paper develops a frequentist model averaging method based on the leave-subject-out cross-validation.This method is applicable not only to averaging longitu
会议
Recurrent event data arise frequently in longitudinal medical studies.In many situations,there are a large portion of subjects without any recurrent events,mani
会议
Under the case-cohort design introduced by Prentice(1986),the covariate histories are ascertained only for the subjects who experience the event of interest(i.e
会议
Proportional hazards(PH) assumption is often used in designing clinical studies with time to event as the primary endpoint.The log-rank test is the most commonl
会议
The cure rate model is most useful for designing studies with time-to-event endpoints such as Overall Survival(OS),when a plateau is reached in the survival cur
会议
会议